Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype.

J Virol

INSERM Unité 380 Laboratoire de Pathologie et Génétique Expérimentales, Institut Cochin de Génétique Moléculaire, Paris, France.

Published: January 1998

Human immunodeficiency virus type 1 (HIV-1) entry into target cells is a multistep process initiated by envelope protein gp120 binding to cell surface CD4. The conformational changes induced by this interaction likely favor a second-step interaction between gp120 and a coreceptor such as CXCR4 or CCR5. Here, we report a spontaneous and stable CD4-independent entry phenotype for the HIV-1 NDK isolate. This mutant strain, which emerged from a population of chronically infected CD4-positive CEM cells, can replicate in CD4-negative human cell lines. The presence of CXCR4 alone renders cells susceptible to infection by the mutant NDK, and infection can be blocked by the CXCR4 natural ligand SDF-1. Furthermore, we have correlated the CD4-independent phenotype with seven mutations in the C2 and C3 regions and the V3 loop. We propose that the mutant gp120 spontaneously acquires a conformation allowing it to interact directly with CXCR4. This virus provides us with a powerful tool to study directly gp120-CXCR4 interactions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC109402PMC
http://dx.doi.org/10.1128/JVI.72.1.512-519.1998DOI Listing

Publication Analysis

Top Keywords

human immunodeficiency
8
immunodeficiency virus
8
virus type
8
ndk isolate
8
cd4-independent entry
8
entry phenotype
8
spontaneous mutations
4
mutations env
4
env gene
4
gene human
4

Similar Publications

Epstein-Barr virus-associated smooth muscle tumors (EBV-SMTs) represent a rare category of soft tissue tumors that are predominantly seen in individuals with compromised immune systems. Pathologically, EBV-SMT has malignant potential because of its unpredictable nature. These tumors can manifest at various anatomical sites or even multiple lesions in different locations.

View Article and Find Full Text PDF

The breadth of the overdose crisis is underestimated because of a lack of quantifying nonfatal overdoses. We estimate the proportion of nonfatal overdoses among all people with HIV (PWH) in British Columbia, Canada, and the prevalence of fatal overdoses among people who had a nonfatal overdose, stratified by sex. A small proportion of PWH who experienced a nonfatal overdose subsequently died of a fatal overdose, signaling opportunities for crucial interventions and treatment to prevent overdose death.

View Article and Find Full Text PDF

Aging with HIV and HIV-associated neurocognitive impairment.

AIDS

March 2025

Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy.

Antiretroviral therapy (ART) is the most effective therapeutic intervention for HIV infection. With improved survival, comorbidities, including neuropsychiatric and HIV-associated neurocognitive impairment (NCI) are of increasing concern to aging people with HIV (PWH). The clinical features and the inter-individual variability of the aging process confound the elucidation of the diagnosis and underlying mechanisms of cognitive dysfunction in aging PWH.

View Article and Find Full Text PDF

[Urinary Salmonella Enteritidis Carriage in a Patient Living with HIV].

Mikrobiyol Bul

January 2025

Sağlık Bilimleri Üniversitesi Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi, Tıbbi Mikrobiyoloji Kliniği, İstanbul.

Tüm dünyada önemli bir halk sağlığı sorunu olan non-tifoidal Salmonella (NTS) sıklıkla gastrointestinal enfeksiyonlara neden olmakta ve taşıyıcılığa yol açabilmektedir. NTS'nin idrarda izolasyonu ve idrar taşıyıcılığı oldukça nadirdir ve predispozan faktörlerin varlığında sıklığı artmaktadır. Kinolon dirençli Salmonella spp.

View Article and Find Full Text PDF

Background: Cabotegravir + rilpivirine (CAB + RPV) administered via intramuscular gluteal injections is the first complete long-acting regimen for maintaining human immunodeficiency virus type 1 (HIV-1) virologic suppression. We present substudy results on short-term repeat intramuscular CAB + RPV long-acting thigh injections in participants with ≥3 years of experience with gluteal administration during the ATLAS-2M study.

Methods: Substudy phases included screening, thigh injection (day 1-week 16), and return to gluteal injection (week 16-week 24).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!